The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
about
Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implicationsUsing drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerGenome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.Status of p53 and p27(KIP1) in Iranian Patients With Oral Squamous Cell Carcinoma.Circulating small non-coding RNA signature in head and neck squamous cell carcinomaCurrent dichotomy between traditional molecular biological and omic research in cancer biology and pharmacology.The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaPhase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.Molecular profiling of head and neck squamous cell carcinoma.Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinomaTargeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.Applications of molecular testing in surgical pathology of the head and neck.The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.Effect of human papillomavirus seropositivity and E2F2 promoter variants on risk of squamous cell carcinomas of oropharynx and oral cavity.Emerging drugs for head and neck cancer.Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review).Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach.Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel.Tumors of the upper aerodigestive tract
P2860
Q26801718-67932F20-379B-46C1-BD34-7502EA252694Q27320602-32B85385-1A27-410A-94D3-1638B9D3C7EDQ35738663-044797BC-E664-454F-B025-43EC94F51DFCQ36266721-6E9CDE5C-D1D0-49BD-A2F6-422D1F9A2178Q36326374-4F3BDB1B-8BAF-4B70-8AE8-03BE719B5C4BQ36363613-C1D46403-BD26-43D2-8485-C713EECD51E2Q37046726-0732C012-AAF3-4852-9D54-C9670ED001F4Q37304652-656F217E-63B4-44CE-A20D-693582007E4BQ37337359-D58E138F-184A-4E40-B9F7-ACF9EFD0B9F8Q37345682-FC3CD3E7-DD06-4575-A1FD-9DF80EB4B1AAQ37641638-7504A5E4-0E61-49C4-A60E-613BE3E28E95Q38245688-8CF03D69-AD93-47BD-94C8-341ADDF7125BQ39070411-7E37FB8D-45A5-4FCE-A832-82B41DF5F78CQ40129971-C4F924A7-EC2B-4FB5-9B8B-ADE60DAB976CQ40546450-73A7A469-DECC-4C26-99CF-7DE8FB2EE439Q45874449-265419CE-0553-4A50-90DD-A959252A0D49Q47546900-17EF7366-C687-40D2-B3C0-FA3714865C9AQ49831105-D046278C-E7A9-4100-B3D3-EB620783AAEFQ50957199-C23342A7-9EF9-4F8B-A387-35B116BC2229Q58426138-2D08A7E2-032E-4059-B4BC-0986CEECF80B
P2860
The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The mutational spectrum of squ ...... ic events and clinical impact.
@en
type
label
The mutational spectrum of squ ...... ic events and clinical impact.
@en
prefLabel
The mutational spectrum of squ ...... ic events and clinical impact.
@en
P2093
P2860
P356
P1433
P1476
The mutational spectrum of squ ...... ic events and clinical impact.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDU143
P577
2014-04-08T00:00:00Z